Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Nato’s European members discuss 3% target for defence spending
    • James Dyson is right to fight for British strawberries
    • Demand for UK rented properties falls for first time since pandemic
    • Luxury real estate brokers charged with sex trafficking
    • ‘We need time’: Syrians in Europe resist calls to return home
  • US
    Sections
    • US Home
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
    Most Read
    • Nato’s European members discuss 3% target for defence spending
    • Luxury real estate brokers charged with sex trafficking
    • Nasdaq’s board diversity rules struck down by US court
    • Dollar’s surge sparks biggest fall in emerging market currencies in 2 years
    • Ayatollah Khamenei defiant even as Iran evacuates thousands from Syria
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Selfridges’ Thai co-owner says it overpaid for luxury store portfolio
    • James Dyson is right to fight for British strawberries
    • Murdoch family feud left hanging over media empire’s future
    • Demand for UK rented properties falls for first time since pandemic
    • Luxury real estate brokers charged with sex trafficking
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • The AI agents are coming
    • Romania’s cancelled election is a lesson in social media manipulation
    • Meta donates $1mn to Trump’s inauguration fund
    • Google races to bring AI-powered ‘agents’ to consumers
    • Microsoft’s Suleyman hires ex-DeepMind staff for AI health unit
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Dollar’s surge sparks biggest fall in emerging market currencies in 2 years
    • The astonishing success of Eurozone bailouts
    • New eras, same bubbles: the forgotten lessons of history
    • FCA looks to fill advice gap on pensions
    • UK fintech Stenn collapsed after Russia money laundering case drew scrutiny
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • James Dyson is right to fight for British strawberries
    • The western myth of the ‘guy we can do business with’
    • The AI agents are coming
    • Romania’s cancelled election is a lesson in social media manipulation
    • The astonishing success of Eurozone bailouts
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Nasdaq’s board diversity rules struck down by US court
    • Why business should not ape football when it comes to pay
    • Winner Parmy Olson on AI: ‘It’s not uncontrollable’
    • Pay UK bosses like football stars, says Lord Spencer
    • Remote and offshore work could hurt audit quality, US regulator warns
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Mitch McConnell: ‘We’re in a very, very dangerous world right now’
    • Pat Boonnitipat expected to lose money on his debut film. It’s become an Asian cultural supernova
    • It’s party season — let the covert interiors appraisals begin
    • Murder at the Castle — Miss Merkel finds her freedom
    • Thought the petrol Jaguar was dead? Think again
  • HTSI
  1. Companies
  2. Health
  • Healthcare
  • Pharmaceuticals
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Health

  • Thursday, 12 December, 2024
    The Big Read
    What other conditions could weight-loss drugs treat?

    Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s

    A montage of the human organs overlaid with Novo Nordisk and Eli Lilly logos
  • Wednesday, 11 December, 2024
    Microsoft Corp
    Microsoft’s Suleyman hires ex-DeepMind staff for AI health unit

    Rival companies are racing to create lucrative applications from cutting-edge technology

    Mustafa Suleyman
  • Tuesday, 10 December, 2024
    Medical science
    Scientists find potential link between ultra-processed foods and cancer

    Fatty molecules also found in UPFs seen at high levels in colorectal tumours

    A University of South Florida researcher working in a lab
  • Monday, 9 December, 2024
    The FT ViewThe editorial board
    Tackling the harms of ultra-processed foods

    Consumers need clear information to make healthier choices about what they eat

    Donuts
  • Friday, 6 December, 2024
    UnitedHealth Group Inc
    UnitedHealth shooting stokes mourning and glee on social media

    Jubilation among some users highlights scale of Americans’ frustration over their health system

    Ambulance drives by a poster outside the Hilton hotel near the scene where Brian Thompson was shot dead in New York City
  • Friday, 6 December, 2024
    Data PointsJohn Burn-Murdoch
    What if the UK isn’t actually the sick man of Europe?

    Britain’s illness-related inactivity crisis looks increasingly like a mirage

    Montage image of a medical professional taking a blood pressure reading from a patient
  • Wednesday, 4 December, 2024
    Food diet
    Ultra-processed foods fatten muscles even if not eaten in large amounts, study finds

    Research intensifies debate over health risks of mass-produced goods made more palatable for consumers

    A burger being held above a tray with sweet potato fries and dips
  • Tuesday, 3 December, 2024
    Food diet
    UK junk food ad ban includes porridge and pitta bread snacks

    Unhealthy foods cannot be shown online or before 9pm under new rules to cut childhood obesity

    An oat-based cereal
  • Monday, 2 December, 2024
    Environment
    England’s environment watchdog told to review risk from lead mines

    Government-ordered report comes after FT investigation into impact of toxic metal on human health

    A scenic view of two hikers walking along a grassy trail, framed by the doorway of a weathered stone ruin against rolling hills
  • Sunday, 1 December, 2024
    Biotech
    Carlyle-backed life sciences investor launches $1.5bn clinical trials fund

    Abingworth wants to pursue royalty-based partnerships with major pharma groups

  • Friday, 29 November, 2024
    UK politics
    ‘I completely changed my mind’: How UK MPs backed assisted dying bill

    Months of scrutiny follow landmark decision as questions remain over how it would be safely implemented

    Labour MP Kim Leadbeater reacts as she meets campaigners after the parliamentary vote on assisted dying was passed
  • Friday, 29 November, 2024
    UK politics
    UK MPs back bill to legalise assisted dying

    Legislators vote to allow some terminally ill people in England and Wales to end their lives

    People wearing pink hats and shirts gather in front of parliament in London. A woman embraces another person while another holds a sign that reads, ‘Legalise assisted dying and let us choose’
  • Friday, 29 November, 2024
    Undercover EconomistTim Harford
    Keep vaccines out of politics

    This is a time for treating people as individuals rather than as members of a tribe

  • Friday, 29 November, 2024
    Soumaya Keynes
    Is there such a thing as too much parental leave?

    Done the wrong way, it can have awkward effects

    Ann Kiernan illustration of a small child drawing a graph on a wall with crayons
  • Thursday, 28 November, 2024
    FT Collecting Supplements
    Art Basel Miami Beach 2024

    The fair’s new director Bridget Finn on selling art in a divided US. Plus: interviews with Anastasia Samoylova and Jesse Lee, the private gallery succession question

    A brightly coloured abstract image which includes one small collaged image of people’s faces
  • Thursday, 28 November, 2024
    Lucy Webster
    The assisted dying bill does not protect sick and disabled people

    This legislation does not contain watertight safeguards, leaving vulnerable groups at risk

  • Thursday, 28 November, 2024
    News in-depthUS healthcare reform
    Robert Kennedy’s fractious battle to fix America’s health

    Radical former Democrat wants to take on Big Pharma — but his team is already arguing

    A montage of Robert F Kennedy Jr with the logo of Pfizer and Wegovy pens in the background
  • Thursday, 28 November, 2024
    Regulation and ‘poor alignment’ are stymying health innovation, says report

    Author recommends breaking ‘siloed’ work practices to spur life sciences sector and improve care

    Medics seen working during an operation
  • Wednesday, 27 November, 2024
    News in-depth
    Palliative care ‘postcode lottery’ casts shadow over assisted dying debate

    Critics of proposed legislation argue for better end-of-life care ahead of vote on Friday

    Elderly woman lying on her bed in a hospital ward
  • Wednesday, 27 November, 2024
    Anjana Ahuja
    On assisted dying, are we really any good at predicting survival?

    Forecasting the last seven days of life is harder than the final 24 hours; beyond that, things become shakier still

    Andy Carter illustration of a doctor leading a patient into a glowing section of a clock suggesting their time has come, having estimated their remaining time left.
  • Tuesday, 26 November, 2024
    Healthcare
    Biden proposes wide expansion of US weight-loss drug coverage

    State-backed insurance programmes would fund drugs for obese patients without separate health conditions

    Boxes of Ozempic and Wegovy made by Novo Nordisk on display at a pharmacy in London
  • Tuesday, 26 November, 2024
    FT SeriesDon’t miss – HTSI’s most popular stories
    Could chanting change your life?

    Today’s classes are as much about stress relief as spirituality. The feeling of elation is an added bonus, too. Time to get it om

    An illustration of a woman chanting, surrounded by swirls of bright colour
  • Monday, 25 November, 2024
    Disease control and prevention
    Global rates of HIV infections and deaths fall sharply

    Africa leads decline but cases must fall faster to meet target of ending designation of Aids as public health threat by 2030

    A woman takes her Antiretroviral drugs (ARVs) pills during the World Aids Day in Kibera
  • Monday, 25 November, 2024
    Biotech
    Biotechs test IPO market despite concerns over Kennedy’s health role

    Trump nominee has caused concern in the industry due to his desire to reduce spending on medicines

    Donald Trump, left, and Robert Kennedy
  • Monday, 25 November, 2024
    Special ReportPlastics and Chemicals
    How harmful are microplastics to human health?

    Scientific research into how plastics affect the body is in its early days

    A close-up of someone examining a specimen dish under a microscope with extra lighting
Previous page You are on page 1 Next page

Most Read

  1. Microsoft’s Suleyman hires ex-DeepMind staff for AI health unit
  2. Scientists find potential link between ultra-processed foods and cancer
  3. What other conditions could weight-loss drugs treat?
  4. Tackling the harms of ultra-processed foods
  5. What if the UK isn’t actually the sick man of Europe?

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
US Pharma and Biotech Summit
How the new market cycle will finance the next period of investing in innovation
Thursday, 15 May 2025New York, NY, USA
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareersSuppliers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:International
UK
Subscribe for full access

Top sections

  • Home
  • World
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • US
    • US Economy
    • Investing in America
    • US Companies
    • US Politics & Policy
    • US Presidential Election 2024
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Schools
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In